Xamoterol
From Wikipedia, the free encyclopedia
Systematic (IUPAC) name | |
---|---|
(RS)-N-(2-{[2-hydroxy-3-(4-hydroxyphenoxy)propyl]amino}ethyl)morpholine-4-carboxamide | |
Clinical data | |
Pregnancy cat. | ? |
Legal status | ? |
Identifiers | |
CAS number | 81801-12-9 |
ATC code | C01CX07 |
PubChem | CID 155774 |
IUPHAR ligand | 538 |
ChemSpider | 137213 |
UNII | 7HE0JQL703 |
KEGG | D06328 |
ChEMBL | CHEMBL75753 |
Chemical data | |
Formula | C16H25N3O5 |
Mol. mass | 339.387 g/mol |
|
|
|
|
(what is this?) (verify) |
Xamoterol is a cardiac stimulant. It works by binding to the β1 adrenergic receptor. It is a 3rd generation adrenergic beta receptor partial agonist. It provides cardiac stimulation at rest but it acts as a blocker during exercise. [1]
References [edit]
- ^ Rang, H. P. (2003). Pharmacology. Edinburgh: Churchill Livingstone. ISBN 0-443-07145-4. Page 163
|
This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it. |